Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Summary

The goal of this observational study is to learn how a physician uses the results of the Percepta® Nasal Swab test to manage people with a newly identified pulmonary nodule. The main questions it aims to answer are: Does the use of the Percepta Nasal swab test reduce the number of invasive procedures in people with a low-risk result and whose nodule is benign? Does the use of the Percepta Nasal swab test decrease the time to treatment in people with a high-risk result and whose nodule is cancer?

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Pulmonary Nodule, Solitary
• Lung Cancer

Eligibility basics and study details

Study type

Observational

Phase

Not applicable

Ages

29 to 85 years

Sex

All

Healthy volunteers

Not accepted

Sponsor

Veracyte, Inc.

Last updated on ClinicalTrials.gov

November 13, 2024

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites